305 related articles for article (PubMed ID: 30879551)
21. Long-term Mortality Risks Among Living Kidney Donors in Korea.
Kim Y; Yu MY; Yoo KD; Jeong CW; Kim HH; Min SI; Ha J; Choi Y; Ko AR; Yun JM; Park SM; Yang SH; Kim DK; Oh KH; Joo KW; Ahn C; Kim YS; Lee H
Am J Kidney Dis; 2020 Jun; 75(6):919-925. PubMed ID: 31866225
[TBL] [Abstract][Full Text] [Related]
22. Relationships Between Clinical, Self-Reported, and Donation Specific Outcomes: A Prospective Follow-up Study 10 Years After Kidney Donation.
Meyer KB; Hartmann A; Mjøen G; Andersen MH
Ann Transplant; 2017 Mar; 22():148-155. PubMed ID: 28321111
[TBL] [Abstract][Full Text] [Related]
23. Role of Transforming Growth Factor-β in Hypertensive Living Kidney Donors.
Bieniasz M; Kieszek R; Kwapisz M; Jędrzejko K; Durlik M; Pączek L; Kwiatkowski A
Transplant Proc; 2018; 50(6):1602-1604. PubMed ID: 30056868
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of Kidney Donors over 60 Years Old: A Single-Center Cohort Study.
Gero D; Dib F; Matter M; Pascual M; Venetz JP; Demartines N; Melloul E
World J Surg; 2017 Nov; 41(11):2940-2948. PubMed ID: 28634839
[TBL] [Abstract][Full Text] [Related]
25. A prospective controlled study of living kidney donors: three-year follow-up.
Kasiske BL; Anderson-Haag T; Israni AK; Kalil RS; Kimmel PL; Kraus ES; Kumar R; Posselt AA; Pesavento TE; Rabb H; Steffes MW; Snyder JJ; Weir MR
Am J Kidney Dis; 2015 Jul; 66(1):114-24. PubMed ID: 25795073
[TBL] [Abstract][Full Text] [Related]
26. Renal Consequences of Diabetes After Kidney Donation.
Ibrahim HN; Berglund DM; Jackson S; Vock DM; Foley RN; Matas AJ
Am J Transplant; 2017 Dec; 17(12):3141-3148. PubMed ID: 28681494
[TBL] [Abstract][Full Text] [Related]
27. Changes in renal function and predictors affecting renal outcome of living kidney donors: a nationwide prospective cohort study.
Kim Y; Kim MJ; Lee YH; Lee JP; Lee JH; Yang J; Kim MS; Kim T; Kang SW; Kim YH;
Nephrology (Carlton); 2021 Jun; 26(6):541-548. PubMed ID: 33764586
[TBL] [Abstract][Full Text] [Related]
28. Long-term Renal Function in Living Kidney Donors Who Had Histological Abnormalities at Donation.
Fahmy LM; Massie AB; Muzaale AD; Bagnasco SM; Orandi BJ; Alejo JL; Boyarsky BJ; Anjum SK; Montgomery RA; Dagher NN; Segev DL
Transplantation; 2016 Jun; 100(6):1294-8. PubMed ID: 27152920
[TBL] [Abstract][Full Text] [Related]
29. Long term metabolic and renal outcomes of kidney donors compared to controls with excellent kidney function.
Grupper A; Angel Y; Baruch A; Schwartz IF; Schwartz D; Nakache R; Goykhman Y; Katz P; Nachmany I; Lubezky N; Weinstein T; Shashar M; Ben-Bassat OK; Berliner S; Rogowski O; Zeltser D; Shapira I; Shenhar-Tsarfaty S
BMC Nephrol; 2019 Jan; 20(1):30. PubMed ID: 30704441
[TBL] [Abstract][Full Text] [Related]
30. Changes in glomerular filtration rate after donation in living kidney donors: a single-center cohort study.
Saito T; Uchida K; Ishida H; Tanabe K; Nitta K
Int Urol Nephrol; 2015 Feb; 47(2):397-403. PubMed ID: 25367358
[TBL] [Abstract][Full Text] [Related]
31. Impact of Cigarette Smoking on Living Kidney Donors.
Yoon YE; Lee HH; Na JC; Huh KH; Kim MS; Kim SI; Kim YS; Han WK
Transplant Proc; 2018 May; 50(4):1029-1033. PubMed ID: 29731061
[TBL] [Abstract][Full Text] [Related]
32. Renal outcome 25 years after donor nephrectomy.
Goldfarb DA; Matin SF; Braun WE; Schreiber MJ; Mastroianni B; Papajcik D; Rolin HA; Flechner S; Goormastic M; Novick AC
J Urol; 2001 Dec; 166(6):2043-7. PubMed ID: 11696703
[TBL] [Abstract][Full Text] [Related]
33. Association of Pre- and Post-Donation Renal Function with Midterm Estimated Glomerular Filtration Rate in Living Kidney Donors: A Retrospective Study.
Park JH; Kim SY; Cho JS; Shin D; Ham SY; Kim H; Kwak YL
Yonsei Med J; 2023 Mar; 64(3):221-227. PubMed ID: 36825349
[TBL] [Abstract][Full Text] [Related]
34. Long-term Follow-up of Living Kidney Donors With Chronic Kidney Disease at 1 Year After Nephrectomy.
Na JC; Park JS; Yoon MG; Lee HH; Yoon YE; Huh KH; Kim YS; Han WK
Transplant Proc; 2018 May; 50(4):1018-1021. PubMed ID: 29731059
[TBL] [Abstract][Full Text] [Related]
35. Investigating Serum Uric Acid as a Risk Factor in the Development of Delayed Renal Recovery in Living Kidney Donors.
Bravo RC; Gamo MB; Lee HH; Yoon YE; Han WK
Transplant Proc; 2017 Jun; 49(5):930-934. PubMed ID: 28583561
[TBL] [Abstract][Full Text] [Related]
36. Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation.
Young A; Hodsman AB; Boudville N; Geddes C; Gill J; Goltzman D; Jassal SV; Klarenbach S; Knoll G; Muirhead N; Prasad GV; Treleaven D; Garg AX;
Am J Kidney Dis; 2012 Jun; 59(6):761-9. PubMed ID: 22093959
[TBL] [Abstract][Full Text] [Related]
37. Renal cortical volume: High correlation with pre- and post-operative renal function in living kidney donors.
Gardan E; Jacquemont L; Perret C; Heudes PM; Gourraud PA; Hourmant M; Frampas E; Limou S
Eur J Radiol; 2018 Feb; 99():118-123. PubMed ID: 29362141
[TBL] [Abstract][Full Text] [Related]
38. Five-year follow-up after live donor nephrectomy - cross-sectional and longitudinal analysis of a prospective cohort within the era of extended donor eligibility criteria.
Janki S; Dols LF; Timman R; Mulder EE; Dooper IM; van de Wetering J; IJzermans JN
Transpl Int; 2017 Mar; 30(3):266-276. PubMed ID: 27717017
[TBL] [Abstract][Full Text] [Related]
39. Short- and long-term follow-up of living kidney donors.
Abdellaoui I; Azzabi A; Sahtout W; Sabri F; Hmida W; Achour A
Saudi J Kidney Dis Transpl; 2019; 30(2):401-420. PubMed ID: 31031377
[TBL] [Abstract][Full Text] [Related]
40. The Minnesota attributable risk of kidney donation (MARKD) study: a retrospective cohort study of long-term (> 50 year) outcomes after kidney donation compared to well-matched healthy controls.
Vock DM; Helgeson ES; Mullan AF; Issa NS; Sanka S; Saiki AC; Mathson K; Chamberlain AM; Rule AD; Matas AJ
BMC Nephrol; 2023 May; 24(1):121. PubMed ID: 37127560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
